Trial Profile
A retrospective study to evaluate the impact of splitting single-tablet regimen of Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate to a double tablet regimen (Emtricitabine/tenofovir-disoproxil-fumarate and efavirenz) on virologic effectiveness at 24 weeks
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Dec 2016
Price :
$35
*
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 30 Dec 2016 New trial record